J Korean Med Sci.
2018 Oct;33(40):e255. 10.3346/jkms.2018.33.e255.
The Infinity War: How to Cope with Carbapenem-resistant Enterobacteriaceae
- Affiliations
-
- 1Division of Infectious Diseases, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Bucheon St. Mary's Hospital, Bucheon, Korea. jhyoo@catholic.ac.kr
- KMID: 2420923
- DOI: http://doi.org/10.3346/jkms.2018.33.e255
Abstract
- Carbapenem-resistant Enterobacteriaceae (CRE) are now spread worldwide. In Korea, the number of CRE isolation is rapidly increasing, and impending endemicity is a concern. To cope well with CRE, thorough infection control, such as active surveillance, early detection, strict contact precaution, cleaning the environment, and antibiotic stewardship is very important. Therapeutic options include polymyxin, tigecycline, fosfomycin or the combination of them with carbapenem, which is currently the mainstay of treatment. In addition, various combination regimens with new carbapenemase inhibitors such as avibactam, vaborbactam, or relebactam, and other classes of antimicrobials such as plazomicin and siderophore cephalosporin are in the process of evaluation.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Carbapenem-resistant Enterobacteriaceae in Korea
- Carbapenem-Resistant Enterobacteriaceae: Rapid Laboratory Diagnosis and Surveillance Culture for Infection Control
- Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea
- Carbapenem resistance in critically important human pathogens isolated from companion animals: a systematic literature review
- Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization
